International Institute for Integrated Medicine, 22 Eden Street, Suite 467, Kingston KT1 1DN, United Kingdom.
Complement Ther Med. 2016 Apr;25:78-85. doi: 10.1016/j.ctim.2015.12.019. Epub 2016 Jan 4.
Develop a criteria catalog serving as a guideline for authors to improve the quality of reporting clinical case reports in homeopathy.
An online Delphi process was initiated with a panel of 19 homeopathic experts from Europe, the USA and India. Homeopathy specific item selection took place in three rounds of adjusting. The selected items can be used as an extension of the CARE clinical case reporting guideline.
Eight homeopathy specific 'core' items were selected from a list of 31 suggested items; (1) the clinical history from a homeopathic perspective; (2) the type of homeopathy; detailed description of the medication--(3) nomenclature, (4) manufacture, (5) galenic form+dosage; outcomes--(6) objective evidence if available, (7) occurrence homeopathic aggravation, (8) assessment possible causal attribution of changes to the homeopathic treatment. A further 4 items were recommended for consideration as optional items when case reports are used for specific, in particular educational, purposes. The 8 core items can be used, merged into 6 items, as a homeopathy specific (HOM-CASE) extension to the CARE clinical case reporting guideline items 6, 9 and 10.
Use of the HOM-CASE guideline extension will contribute to transparent and accurate reporting and can significantly improve the quality and reliability of clinical case reports in homeopathy.
制定一个标准目录，作为作者提高顺势疗法临床病例报告质量的指南。
采用在线德尔菲法，邀请来自欧洲、美国和印度的 19 名顺势疗法专家组成专家组。对特定于顺势疗法的项目进行了三轮调整。选定的项目可以作为 CARE 临床病例报告指南的扩展。
从建议的 31 项中，选择了 8 项特定于顺势疗法的“核心”项目；（1）从顺势疗法角度的临床病史；（2）顺势疗法类型；详细描述药物——（3）命名法、（4）制造、（5）赋形剂形式+剂量；结果——（6）如有客观证据，（7）出现顺势加剧，（8）评估对顺势治疗变化的可能因果归因。另外 4 项被推荐作为特定的，特别是教育目的的病例报告的可选项目。这 8 项核心项目可以合并为 6 项，作为对 CARE 临床病例报告指南项目 6、9 和 10 的顺势疗法特定（HOM-CASE）扩展。
使用 HOM-CASE 指南扩展将有助于透明和准确的报告，并可显著提高顺势疗法临床病例报告的质量和可靠性。
